Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy

This clinical research aims to determine if concurrent chemotherapy and radiation therapy is more effective than sequential chemotherapy and radiation therapy for patients with stage IIB-III breast cancer. It seeks to answer the following key questions: 1. When compared to sequential treatment, does concurrent chemoradiotherapy increase disease-free survival? 2. What effects does concurrent treatment have on post-operative look, quality of life, and side effects including arm swelling (lymphoedema)? 3. What are each treatment approach's financial costs? Researchers will compare the following

Trial Details

NCT ID
NCT06926543
Phase
PHASE3
Sponsor
Dr. Tabassum Wadasadawala
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Chemoradiation
Locations (sample)
  • Vishkhapatnam, Andhra Pradesh, India
  • Mumbai, Maharasthra, India|19.07283,72.88261
  • New Chandigarh, Punjab, India
  • Sangrur, Punjab, India|30.24506,75.84488
  • Varanasi, Uttar Pradesh, India|25.31668,83.01041

Key Eligibility Criteria

  • Pathologically confirmed invasive breast cancer
  • Stage IIB-III invasive breast cancer (AJCC 8th edition)
  • Patients planned for adjuvant chemotherapy and adjuvant radiotherapy
  • Patients fit to receive adjuvant chemotherapy and radiotherapy

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →